Clinical Trial Update: Study of ZKAB001 for Maintenance Therapy in Patients With High-grade Osteosarcoma After Adjuvant Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ZKAB001 as maintenance therapy after adjuvant chemotherapy in patients with high-grade osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• ZKAB001 (PD-L1 antibody)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: High-grade Osteosarcoma | Phase 3 | Status: UNKNOWN